Understanding and preventing complications of liver cirrhosis
Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
['FUNDING_U01'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10909255
This study is looking for ways to help people with cirrhosis, a serious liver condition, by finding better treatments and understanding how things like race and lifestyle can affect their health, especially for those at higher risk.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10909255 on ClinicalTrials.gov |
What this research studies
This research focuses on the rising prevalence of cirrhosis, a severe liver condition that leads to significant health issues and mortality. It aims to identify effective preventative measures, including treatment of underlying liver diseases and monitoring for complications. The study will also explore the impact of social determinants of health on cirrhosis outcomes, particularly in high-risk populations such as racial/ethnic minorities and individuals with substance use disorders. By investigating potential therapies and risk factors, the research seeks to improve survival rates and quality of life for patients with cirrhosis.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with cirrhosis, particularly those from high-risk groups such as racial/ethnic minorities and those with substance use disorders.
Not a fit: Patients with early-stage liver disease or those without cirrhosis may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing complications associated with liver cirrhosis, ultimately enhancing patient survival and quality of life.
How similar studies have performed: Previous research has shown promise in understanding and managing complications of liver diseases, indicating that this approach could yield valuable insights.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KHALILI, MANDANA — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: KHALILI, MANDANA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.